Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

By continuing to view this video or podcast, you confirm that you are a healthcare professional. Mundipharma owns all rights, including copyrights, to this recording. The recording (or any link to it) may not be changed, supplemented or redistributed without the express written consent of Mundipharma.

CAPA and IAPA: The role of viral-fungal host interactions

Martin Hoenigl discusses the major risk factors for COVID-19- and influenza-associated invasive pulmonary aspergillosis, their similarities and differences, and challenges in their diagnosis

SciA-AFN-2400015 | February 2024